Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Tamil Nadu
Monsoon
Kargil Vijay Diwas
Aadhaar-PAN Linking
ITR Deadline
Income Tax Return
Coronavirus India
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / COVID-19: DCGI gives approval for phase-2 clinical trials of Colchicine
India

COVID-19: DCGI gives approval for phase-2 clinical trials of Colchicine

COVID-19: DCGI gives approval for phase-2 clinical trials of Colchicine
Written by Sagar
Jun 12, 2021, 04:57 pm 2 min read
COVID-19: DCGI gives approval for phase-2 clinical trials of Colchicine
Colchicine has been approved for phase-2 clinical trials on COVID-19 patients.

India's top drug regulator - the Drugs Controller General of India (DCGI) - has given approval to carry out phase-2 clinical trials of Colchicine on COVID-19 patients. The re-purposed drug, which is already approved for gout and related inflammatory conditions, is expected to reduce cardiac complications in coronavirus patients. The Council of Scientific & Industrial Research (CSIR) made the announcement today.

Quote
Will undertake a two-arm phase-II clinical trial: CSIR

"The CSIR and Laxai Life Sciences Pvt. Ltd Hyderabad have been given the regulatory approval by DCGI to undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine...during the treatment of COVID-19 patients," the CSIR said in a statement.

Details
'Colchicine an important therapeutic intervention for COVID-19 patients'

Colchicine, when administered along with the standard care, can potentially prove beneficial for coronavirus patients with cardiac comorbidities and for reducing pro-inflammatory cytokines, Dr. Shekhar Mande, the Director General of CSIR, said, according to PTI. Several studies have confirmed that many COVID-19 patients develop cardiac issues during the course of the infection, which further increases their risk of death, Dr. Mande added.

Study
Majority of COVID-19 patients developed heart issues: Study

According to a study published last year in the medical journal JAMA, a majority of people who had recovered from the coronavirus in the past two to three months suffered abnormalities in the heart. Researchers had also found myocardial inflammation in many of the patients who were tested. Most of these patients had notably not required hospitalization, the study said.

Trials
Trials to be completed in coming 8-10 weeks

The CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad and CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu will reportedly partner in the trials for Colchicine. The enrollment of patients for these trials has already started and the trials are expected to be completed in the coming 8-10 weeks, according to Ram Upadhayay, the CEO of Laxai Life Sciences.

Coronavirus in India
India's coronavirus situation

After facing the world's worst coronavirus outbreak, India's COVID-19 situation is finally improving. In the past 24 hours, the country reported 84,332 fresh coronavirus cases - the lowest daily surge in 70 days. Nearly 25 crore doses of coronavirus vaccines have been administered across India, but only 3.4% of the total population has been fully vaccinated.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Sagar
Sagar
Twitter
Sagar covers national news for NewsBytes. He has previously worked as an editorial intern at NDTV. Over the course of his near three-year career, Sagar has gained experience in news writing, copy editing, and video production. He holds a Bachelor's degree in Journalism and Mass Communication from the University of Delhi.
Latest
Health & Wellness
Council of Scientific and Industrial Research
Drugs Controller General of India
Coronavirus
COVID-19
Related
Latest
2022 CWG: Indian women's hockey team beats Wales 3-1
2022 CWG: Indian women's hockey team beats Wales 3-1 Sports
Happy birthday, Harry Potter! Our favorite Harry moments from series
Happy birthday, Harry Potter! Our favorite Harry moments from series Entertainment
Today's cryptocurrency prices: Check Bitcoin, Ethereum, Dogecoin, and Tether rates
Today's cryptocurrency prices: Check Bitcoin, Ethereum, Dogecoin, and Tether rates Business
After Sanjay Rout's no-show, ED raids his house
After Sanjay Rout's no-show, ED raids his house India
2022 Commonwealth Games: Here's India's schedule for July 31
2022 Commonwealth Games: Here's India's schedule for July 31 Sports
Health & Wellness
5 yoga asanas to prevent anemia and increase hemoglobin levels
5 yoga asanas to prevent anemia and increase hemoglobin levels Lifestyle
Here's how eating mushrooms can boost your health
Here's how eating mushrooms can boost your health Lifestyle
World Hepatitis Day 2022: History, significance, causes and symptoms
World Hepatitis Day 2022: History, significance, causes and symptoms Lifestyle
5 yoga asanas to improve blood circulation in your body
5 yoga asanas to improve blood circulation in your body Lifestyle
Which suits you better - aerobic exercises or weight training?
Which suits you better - aerobic exercises or weight training? Lifestyle
More News
Council of Scientific and Industrial Research
Seropositivity for COVID-19 is less in smokers, vegetarians: CSIR survey
Seropositivity for COVID-19 is less in smokers, vegetarians: CSIR survey Technology
'Feluda' coronavirus test: A game-changer in India's fight against COVID-19?
'Feluda' coronavirus test: A game-changer in India's fight against COVID-19? India
Health Minister promotes AYUSH's coronavirus treatment protocol, IMA asks questions
Health Minister promotes AYUSH's coronavirus treatment protocol, IMA asks questions India
Brazilian study suggests dengue antibodies could offer protection against COVID-19
Brazilian study suggests dengue antibodies could offer protection against COVID-19 Technology
COVID-19 detection in 30 seconds? Delhi tests four Israeli technologies
COVID-19 detection in 30 seconds? Delhi tests four Israeli technologies India
More News
Drugs Controller General of India
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
Biological E's Corbevax vaccine approved for children aged 12-18 years
Biological E's Corbevax vaccine approved for children aged 12-18 years India
New anti-COVID drug may cost up to Rs. 3,000: Report
New anti-COVID drug may cost up to Rs. 3,000: Report India
More News
Coronavirus
How long does immunity last after COVID-19?
How long does immunity last after COVID-19? Technology
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming India
COVID-19: India logs 7,584 fresh cases, 24 more fatalities
COVID-19: India logs 7,584 fresh cases, 24 more fatalities India
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
More News
COVID-19
Biden tests positive for COVID-19; rare case of 'rebound positivity'
Biden tests positive for COVID-19; rare case of 'rebound positivity' World
Indian medical students from China, Ukraine now eligible for FMGE
Indian medical students from China, Ukraine now eligible for FMGE Career
Monkeypox scare: WHO advises bisexual men to limit sexual partners
Monkeypox scare: WHO advises bisexual men to limit sexual partners World
MP horror: 30 students vaccinated for COVID-19 with single syringe
MP horror: 30 students vaccinated for COVID-19 with single syringe India
#NewsBytesExplainer: Is monkeypox the next epidemic India should worry about?
#NewsBytesExplainer: Is monkeypox the next epidemic India should worry about? India
More News
Related
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
COVAXIN trial data for children aged 2-18 submitted to DCGI
COVAXIN trial data for children aged 2-18 submitted to DCGI India
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity' World
Reliance Life Sciences gets approval for COVID-19 vaccine trial
Reliance Life Sciences gets approval for COVID-19 vaccine trial India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022